Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, a leader in the pharmaceutical preparation manufacturing industry, is headquartered in the United States. Founded in 2002, the company has made significant strides in the development of RNA interference (RNAi) therapeutics, focusing on rare genetic diseases and other serious conditions.
With a robust pipeline of innovative products, Alnylam's core offerings include ONPATTRO® and GIVLAARI®, which are designed to address unmet medical needs through their unique mechanisms of action. The company has established a strong market position, recognised for its pioneering role in advancing RNAi technology.
Alnylam's commitment to scientific excellence and patient-centric solutions has garnered numerous accolades, solidifying its reputation as a trailblazer in the biopharmaceutical landscape.
+2 vs industry average
Alnylam Pharmaceuticals’s score of 40 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Alnylam Pharmaceuticals?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Alnylam Pharmaceuticals's reported carbon emissions
Alnylam Pharmaceuticals, a US-based company in the Pharmaceutical Preparation Manufacturing industry, reported a total of approximately 182.4 million kg CO2e emissions in 2024. This includes Scope 1 emissions of about 3.8 million kg CO2e, Scope 2 emissions of approximately 8.0 million kg CO2e (market-based), and Scope 3 emissions amounting to about 160.4 million kg CO2e. For the year 2023, Alnylam Pharmaceuticals' total emissions were approximately 180.4 million kg CO2e, comprising around 3.5 million kg CO2e in Scope 1, about 9.9 million kg CO2e for Scope 2 (market-based), and approximately 151.4 million kg CO2e in Scope 3. In 2022, the company's total emissions were roughly 177.2 million kg CO2e, with Scope 1 at approximately 4.1 million kg CO2e, Scope 2 at about 10.1 million kg CO2e (market-based), and Scope 3 at around 143.1 million kg CO2e. Alnylam Pharmaceuticals has established climate commitments, aiming to reduce its Scope 1 emissions by 30% from 2020 levels by 2030 and its Scope 2 emissions by 30% from 2020 levels by 2030. Key contributors to Alnylam Pharmaceuticals' Scope 3 emissions in 2024 include purchased goods and services, accounting for approximately 138.2 million kg CO2e, and business travel at about 5.1 million kg CO2e. In 2023, purchased goods and services were the largest contributor to Scope 3 emissions at approximately 126.5 million kg CO2e. For 2022, purchased goods and services also represented the most significant portion of Scope 3 emissions, at approximately 116.4 million kg CO2e.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Alnylam Pharmaceuticals’s Climate Goals (2030 & 2050)
2 goals2030
30% reduction in Scope 2
We aim to reduce our Scope 2 emissions by 30% from 2020 levels by 2030.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
9 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project